Briva Tablet 50 mg contains Brivaracetam, a newer-generation antiepileptic medication used for the management of seizure disorders. It is mainly prescribed as adjunctive therapy for patients with epilepsy who experience partial-onset (focal) seizures. With its targeted mechanism of action and predictable safety profile, Briva Tablet 50 mg supports effective seizure control and long-term neurological stability.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each tablet contains:

• Brivaracetam 50 mg

Therapeutic Class

• Antiepileptic drug

• Central nervous system (CNS) active agent

Pharmacology and Mechanism of Action

Brivaracetam acts by selectively binding to synaptic vesicle protein 2A (SV2A), a protein involved in the regulation of neurotransmitter release at synaptic junctions in the brain. This high-affinity binding modulates synaptic transmission and reduces neuronal hyperexcitability, which is responsible for seizure generation and propagation.

Brivaracetam is rapidly absorbed after oral administration and demonstrates linear pharmacokinetics. It provides consistent plasma concentrations with regular dosing and shows a low potential for clinically significant drug–drug interactions. Its selective action allows effective seizure control with minimal cognitive impairment in most patients.

Indications

Briva Tablet 50 mg is indicated for:

• Treatment of partial-onset (focal) seizures

• Adjunctive therapy in epilepsy management

• Seizure control in adults and adolescents, as prescribed by a physician

Dosage and Administration

Briva Tablet is administered orally, with or without food, according to medical advice. The dosage is individualized based on the patient’s condition, response to treatment, and tolerability. Tablets should be swallowed whole with water and taken at the same times each day for optimal seizure control.

Abrupt discontinuation of brivaracetam should be avoided, as it may lead to increased seizure frequency.

Benefits

• Effective control of partial-onset seizures

• Targeted SV2A mechanism ensures reliable efficacy

• Favorable tolerability for long-term use

• Minimal drug interaction potential

• Convenient oral tablet formulation

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Use with caution in patients with hepatic impairment; dose adjustments may be required

• Monitor patients for mood or behavioral changes, including depression or irritability

• Alcohol intake should be avoided due to increased CNS effects

• Not recommended to stop treatment suddenly without medical supervision

• Use during pregnancy and breastfeeding only if the potential benefits outweigh the risks

Storage

Store below 30°C in a dry place. Protect from moisture and direct light. Keep out of reach of children.